| 2IEG: reference: Development of potent, orally active 1-substituted-3,4-dihydro-2-quinolone glycogen phosphorylase inhibitors., Birch AM, Kenny PW, Oikonomakos NG, Otterbein L, Schofield P, Whittamore PR, Whalley DP, Bioorg Med Chem Lett. 2006 Oct 19;. PMID: 17095214 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).